Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 4 (1)

Trial Status

Completed3
Active Not Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT00410241Active Not Recruiting

ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

NCT06932874Phase 4RecruitingPrimary

Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease

NCT03235427Completed

The CAROLE (CArdiac Related Oncologic Late Effects) Study

NCT01816854CompletedPrimary

Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent

NCT01632501Not ApplicableCompletedPrimary

Safety and Efficacy of the Percutaneous Intervention Performed With Devices of a Single-brand

Showing all 5 trials

Research Network

Activity Timeline